<record>
  <datafield tag="024" ind1="7" ind2=" ">
    <subfield code="a">10.1016/j.apradiso.2017.03.015</subfield>
    <subfield code="2">DOI</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Sarasamkan, Jiradanai</subfield>
    <subfield code="v">Center of Excellence for Innovation in Drug Design and Discovery, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayutthaya Road, Bangkok, 10400, Thailand</subfield>
    <subfield code="v">Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, Leipzig, 04318, Germany</subfield>
    <subfield code="v">National Cyclotron and PET Centre, Chulabhorn Hospital, 54 Kamphaeng Phet 6 Road, Bangkok, 10210, Thailand</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Radiosynthesis of (S)-[ 18 F]T1: The first PET radioligand for molecular imaging of α3β4 nicotinic acetylcholine receptors</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2017-03-19</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Recent pharmacologic data revealed the implication of α3β4 nicotinic acetylcholine receptors (nAChRs) in nicotine and drug addiction. To image α3β4 nAChRs in vivo, we aimed to establish the synthesis of a [ 18 F]-labelled analog of the highly affine and selective α3β4 ligand ( S )−3-(4-(4-fluorophenyl)−1 H −1,2,3-triazol-1-yl)quinuclidine (( S )- T1 ). ( S )-[ 18 F] T1 was synthesized from ethynyl-4-[ 18 F]fluorobenzene ([ 18 F] 5 ) and ( S )-azidoquinuclidine by click reaction.</subfield>
    <subfield code="9">Elsevier</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="f">© 2017 Elsevier Ltd. All rights reserved.</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">α3β4 Nicotinic acetylcholine receptor</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Click reaction</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Drug addiction</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Positron Emission Tomography</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">18 F-Radioligand ( S )-[ 18 F] T1</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Radiofluorination</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">18F-Radioligand (S)-[18F]T1</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Fischer, Steffen</subfield>
    <subfield code="v">Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, Leipzig, 04318, Germany</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Deuther-Conrad, Winnie</subfield>
    <subfield code="v">Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, Leipzig, 04318, Germany</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ludwig, Friedrich-Alexander</subfield>
    <subfield code="v">Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, Leipzig, 04318, Germany</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Scheunemann, Matthias</subfield>
    <subfield code="v">Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, Leipzig, 04318, Germany</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Arunrungvichian, Kuntarat</subfield>
    <subfield code="v">Center of Excellence for Innovation in Drug Design and Discovery, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayutthaya Road, Bangkok, 10400, Thailand</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Vajragupta, Opa</subfield>
    <subfield code="v">Center of Excellence for Innovation in Drug Design and Discovery, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayutthaya Road, Bangkok, 10400, Thailand</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Brust, Peter</subfield>
    <subfield code="v">Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, Leipzig, 04318, Germany</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="p">Appl.Radiat.Isot.</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">HEP</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">Citeable</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">Published</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Azam, L.</subfield>
    <subfield code="h">Winzer-Serhan, U.H.</subfield>
    <subfield code="h">Chen, Y.L.</subfield>
    <subfield code="h">Leslie, F.M.</subfield>
    <subfield code="t">Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons</subfield>
    <subfield code="v">444</subfield>
    <subfield code="y">2002</subfield>
    <subfield code="o">Azam et al, 2002</subfield>
    <subfield code="s">J.Comp.Neurol.,444,260</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Balfour, D.J.K.</subfield>
    <subfield code="t">The neuronal pathways mediating the behavioral and addictive properties of nicotine</subfield>
    <subfield code="p">Berlin, Heidelberg: Springer</subfield>
    <subfield code="y">2009</subfield>
    <subfield code="e">Henningfield,J.E.</subfield>
    <subfield code="e">London,E.D.</subfield>
    <subfield code="e">Pogun,S.</subfield>
    <subfield code="q">Nicotine Psychopharmacology.</subfield>
    <subfield code="o">Balfour, 2009</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Barrett, S.P.</subfield>
    <subfield code="h">Boileau, I.</subfield>
    <subfield code="h">Okker, J.</subfield>
    <subfield code="h">Pihl, R.O.</subfield>
    <subfield code="h">Dagher, A.</subfield>
    <subfield code="t">The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [ 11 C]raclopride</subfield>
    <subfield code="v">54</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Barrett et al, 2004</subfield>
    <subfield code="s">Synapse,54,65</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Berrettini, W.</subfield>
    <subfield code="h">Yuan, X.</subfield>
    <subfield code="h">Tozzi, F.</subfield>
    <subfield code="h">Song, K.</subfield>
    <subfield code="h">Francks, C.</subfield>
    <subfield code="h">Chilcoat, H.</subfield>
    <subfield code="h">Waterworth, D.</subfield>
    <subfield code="h">Muglia, P.</subfield>
    <subfield code="h">Mooser, V.</subfield>
    <subfield code="t">α−5/α−3 nicotinic receptor subunit alleles increase risk for heavy smoking</subfield>
    <subfield code="v">13</subfield>
    <subfield code="y">2008</subfield>
    <subfield code="o">Berrettini et al, 2008</subfield>
    <subfield code="s">Mol.Psychiatr.,13,368</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Chatterjee, S.</subfield>
    <subfield code="h">Steensland, P.</subfield>
    <subfield code="h">Simms, J.A.</subfield>
    <subfield code="h">Holgate, J.</subfield>
    <subfield code="h">Coe, J.W.</subfield>
    <subfield code="h">Hurst, R.S.</subfield>
    <subfield code="h">Shaffer, C.L.</subfield>
    <subfield code="h">Lowe, J.</subfield>
    <subfield code="h">Rollema, H.</subfield>
    <subfield code="h">Bartlett, S.E.</subfield>
    <subfield code="t">Partial agonists of the α3β4⁎ neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats</subfield>
    <subfield code="v">36</subfield>
    <subfield code="y">2011</subfield>
    <subfield code="o">Chatterjee et al, 2011</subfield>
    <subfield code="s">Neuropsychopharmacol.,36,603</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Coenen, H.H.</subfield>
    <subfield code="t">Fluorine-18 labeling methods: features and possibilities of basic reactions</subfield>
    <subfield code="p">Berlin, Heidelberg: Springer</subfield>
    <subfield code="y">2007</subfield>
    <subfield code="e">Schubiger,P.A.</subfield>
    <subfield code="e">Lehmann,L.</subfield>
    <subfield code="e">Friebe,M.</subfield>
    <subfield code="q">PET Chemistry: The Driving Force in Molecular Imaging.</subfield>
    <subfield code="o">Coenen, 2007</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Dani, J.A.</subfield>
    <subfield code="h">Bertrand, D.</subfield>
    <subfield code="t">Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system</subfield>
    <subfield code="v">47</subfield>
    <subfield code="y">2007</subfield>
    <subfield code="o">Dani and Bertrand, 2007</subfield>
    <subfield code="s">Annu.Rev.Pharmacol.Toxicol.,47,699</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Deuther-Conrad, W.</subfield>
    <subfield code="h">Fischer, S.</subfield>
    <subfield code="h">Hiller, A.</subfield>
    <subfield code="h">Nielsen, E.Ø.</subfield>
    <subfield code="h">Timmermann, D.B.</subfield>
    <subfield code="h">Steinbach, J.</subfield>
    <subfield code="h">Sabri, O.</subfield>
    <subfield code="h">Peters, D.</subfield>
    <subfield code="h">Brust, P.</subfield>
    <subfield code="t">Molecular imaging of α7 nicotinic acetylcholine receptors: design and evaluation of the potent radioligand [ 18 F]NS10743</subfield>
    <subfield code="v">36</subfield>
    <subfield code="y">2009</subfield>
    <subfield code="o">Deuther-Conrad et al, 2009</subfield>
    <subfield code="s">Eur.J.Nucl.Med.Mol.I.,36,791</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Ermert, J.</subfield>
    <subfield code="h">Hocke, C.</subfield>
    <subfield code="h">Ludwig, T.</subfield>
    <subfield code="h">Gail, R.</subfield>
    <subfield code="h">Coenen, H.H.</subfield>
    <subfield code="t">Comparison of pathways to the versatile synthon of no‐carrier‐added 1‐bromo‐4‐[ 18 F]fluorobenzene</subfield>
    <subfield code="v">47</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Ermert et al, 2004</subfield>
    <subfield code="s">J.Labelled Compd Rad,47,429</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Fowler, C.D.</subfield>
    <subfield code="h">Arends, M.A.</subfield>
    <subfield code="h">Kenny, P.J.</subfield>
    <subfield code="t">Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice</subfield>
    <subfield code="v">19</subfield>
    <subfield code="y">2008</subfield>
    <subfield code="o">Fowler et al, 2008</subfield>
    <subfield code="s">Behav.Pharmacol.,19,461</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Gail, R.</subfield>
    <subfield code="h">Coenen, H.</subfield>
    <subfield code="t">A one step preparation of the n.c.a. fluorine-18 labelled synthons: 4-fluorobromobenzene and 4-fluoroiodobenzene</subfield>
    <subfield code="v">45</subfield>
    <subfield code="y">1994</subfield>
    <subfield code="o">Gail and Coenen, 1994</subfield>
    <subfield code="s">Appl.Radiat.Isotopes,45,105</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Glaser, M.</subfield>
    <subfield code="h">Luthra, S.K.</subfield>
    <subfield code="h">Brady, F.</subfield>
    <subfield code="t">Applications of positron-emitting halogens in PET oncology (Review)</subfield>
    <subfield code="v">22</subfield>
    <subfield code="y">2003</subfield>
    <subfield code="o">Glaser et al, 2003</subfield>
    <subfield code="s">Int.J.Oncol.,22,253</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Glick, S.D.</subfield>
    <subfield code="h">Maisonneuve, I.M.</subfield>
    <subfield code="h">Dickinson, H.A.</subfield>
    <subfield code="t">18‐MC reduces methamphetamine and nicotine self‐administration in rats</subfield>
    <subfield code="v">11</subfield>
    <subfield code="y">2000</subfield>
    <subfield code="o">Glick et al, 2000</subfield>
    <subfield code="s">Neuroreport,11,2013</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Glick, S.D.</subfield>
    <subfield code="h">Maisonneuve, I.M.</subfield>
    <subfield code="h">Kitchen, B.A.</subfield>
    <subfield code="h">Fleck, M.W.</subfield>
    <subfield code="t">Antagonism of α3β4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration</subfield>
    <subfield code="v">438</subfield>
    <subfield code="y">2002</subfield>
    <subfield code="o">Glick et al, 2002</subfield>
    <subfield code="s">Eur.J.Pharmacol.,438,99</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Glick, S.D.</subfield>
    <subfield code="h">Sell, E.M.</subfield>
    <subfield code="h">McCallum, S.E.</subfield>
    <subfield code="h">Maisonneuve, I.M.</subfield>
    <subfield code="t">Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administration</subfield>
    <subfield code="v">669</subfield>
    <subfield code="y">2011</subfield>
    <subfield code="o">Glick et al, 2011</subfield>
    <subfield code="s">Eur.J.Pharmacol.,669,71</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Hansch, C.</subfield>
    <subfield code="h">Leo, A.</subfield>
    <subfield code="h">Taft, R.W.</subfield>
    <subfield code="t">A Survey of Hammett Substituent Constants and Resonance and Field Parameters</subfield>
    <subfield code="v">91</subfield>
    <subfield code="y">1991</subfield>
    <subfield code="o">Hansch et al, 1991</subfield>
    <subfield code="s">Chem.Rev.,91,165</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Harpsøe, K.</subfield>
    <subfield code="h">Hald, H.</subfield>
    <subfield code="h">Timmermann, D.B.</subfield>
    <subfield code="h">Jensen, M.L.</subfield>
    <subfield code="h">Dyhring, T.</subfield>
    <subfield code="h">Nielsen, E.O.</subfield>
    <subfield code="h">Peters, D.</subfield>
    <subfield code="h">Balle, T.</subfield>
    <subfield code="h">Gajhede, M.</subfield>
    <subfield code="h">Kastrup, J.S.</subfield>
    <subfield code="h">Ahring, P.K.</subfield>
    <subfield code="t">Molecular determinants of subtype-selective efficacies of cytisine and the novel compound NS3861 at heteromeric nicotinic acetylcholine receptors</subfield>
    <subfield code="v">288</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Harpsøe et al, 2013</subfield>
    <subfield code="s">J.Biol.Chem.,288,2559</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Holl, K.</subfield>
    <subfield code="h">Schepmann, D.</subfield>
    <subfield code="h">Fischer, S.</subfield>
    <subfield code="h">Ludwig, F.-A.</subfield>
    <subfield code="h">Hiller, A.</subfield>
    <subfield code="h">Donat, C.K.</subfield>
    <subfield code="h">Deuther-Conrad, W.</subfield>
    <subfield code="h">Brust, P.</subfield>
    <subfield code="h">Wunsch, B.</subfield>
    <subfield code="t">Asymmetric synthesis of spirocyclic 2-benzopyrans for positron emission tomography of s 1 receptors in the brain</subfield>
    <subfield code="v">7</subfield>
    <subfield code="y">2014</subfield>
    <subfield code="o">Holl et al, 2014</subfield>
    <subfield code="s">Pharmaceuticals,7,78</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Jackson, K.J.</subfield>
    <subfield code="h">Sanjakdar, S.S.</subfield>
    <subfield code="h">Muldoon, P.P.</subfield>
    <subfield code="h">McIntosh, J.M.</subfield>
    <subfield code="h">Damaj, M.I.</subfield>
    <subfield code="t">The α3β4⁎ nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the α5 subunit in the mouse</subfield>
    <subfield code="v">70</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Jackson et al, 2013</subfield>
    <subfield code="s">Neuropharmacology,70,228</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Khroyan, T.V.</subfield>
    <subfield code="h">Yasuda, D.</subfield>
    <subfield code="h">Toll, L.</subfield>
    <subfield code="h">Polgar, W.E.</subfield>
    <subfield code="h">Zaveri, N.T.</subfield>
    <subfield code="t">High affinity α3β4 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice</subfield>
    <subfield code="v">97</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Khroyan et al, 2015</subfield>
    <subfield code="s">Biochem.Pharmacol.,97,531</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Koob, G.F.</subfield>
    <subfield code="h">Volkow, N.D.</subfield>
    <subfield code="t">Neurocircuitry of addiction</subfield>
    <subfield code="v">35</subfield>
    <subfield code="y">2010</subfield>
    <subfield code="o">Koob and Volkow, 2010</subfield>
    <subfield code="s">Neuropsychopharmacol.,35,217</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Maisonneuve, I.M.</subfield>
    <subfield code="h">Glick, S.D.</subfield>
    <subfield code="t">Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment</subfield>
    <subfield code="v">75</subfield>
    <subfield code="y">2003</subfield>
    <subfield code="o">Maisonneuve and Glick, 2003</subfield>
    <subfield code="s">Pharmacol.Biochem.Behav.,75,607</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Matera, C.</subfield>
    <subfield code="h">Quadri, M.</subfield>
    <subfield code="h">Sciaccaluga, M.</subfield>
    <subfield code="h">Pomè, D.Y.</subfield>
    <subfield code="h">Fasoli, F.</subfield>
    <subfield code="h">De Amici, M.</subfield>
    <subfield code="h">Fucile, S.</subfield>
    <subfield code="h">Gotti, C.</subfield>
    <subfield code="h">Dallanoce, C.</subfield>
    <subfield code="h">Grazioso, G.</subfield>
    <subfield code="t">Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the a3b4 nicotinic acetylcholine receptor subtype</subfield>
    <subfield code="v">108</subfield>
    <subfield code="y">2016</subfield>
    <subfield code="o">Matera et al, 2016</subfield>
    <subfield code="s">Eur.J.Med.Chem.,108,392</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">McCallum, S.E.</subfield>
    <subfield code="h">Cowe, M.A.</subfield>
    <subfield code="h">Lewis, S.W.</subfield>
    <subfield code="h">Glick, S.D.</subfield>
    <subfield code="t">α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo</subfield>
    <subfield code="v">63</subfield>
    <subfield code="y">2012</subfield>
    <subfield code="o">McCallum et al, 2012</subfield>
    <subfield code="s">Neuropharmacology,63,434</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Mirfeizi, L.</subfield>
    <subfield code="h">Campbell-Verduyn, L.</subfield>
    <subfield code="h">Dierckx, R.A.</subfield>
    <subfield code="h">Feringa, B.L.</subfield>
    <subfield code="h">Elsinga, P.H.</subfield>
    <subfield code="t">Application of click chemistry for PET</subfield>
    <subfield code="v">17</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Mirfeizi et al, 2013</subfield>
    <subfield code="s">Curr.Org.Chem.,17,2108</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Pagliai, F.</subfield>
    <subfield code="h">Pirali, T.</subfield>
    <subfield code="h">Del Grosso, E.</subfield>
    <subfield code="h">Di Brisco, R.</subfield>
    <subfield code="h">Tron, G.C.</subfield>
    <subfield code="h">Sorba, G.</subfield>
    <subfield code="h">Genazzani, A.A.</subfield>
    <subfield code="t">Rapid synthesis of triazole-modified resveratrol analogues via click chemistry</subfield>
    <subfield code="v">49</subfield>
    <subfield code="y">2006</subfield>
    <subfield code="o">Pagliai et al, 2006</subfield>
    <subfield code="s">J.Med.Chem.,49,467</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Perry, D.C.</subfield>
    <subfield code="h">Xiao, Y.</subfield>
    <subfield code="h">Nguyen, H.N.</subfield>
    <subfield code="h">Musachio, J.L.</subfield>
    <subfield code="h">Dávila‐García, M.I.</subfield>
    <subfield code="h">Kellar, K.J.</subfield>
    <subfield code="t">Measuring nicotinic receptors with characteristics of α4β2, α3β2 and α3β4 subtypes in rat tissues by autoradiography</subfield>
    <subfield code="v">82</subfield>
    <subfield code="y">2002</subfield>
    <subfield code="o">Perry et al, 2002</subfield>
    <subfield code="s">J.Neurochem,82,468</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Picciotto, M.R.</subfield>
    <subfield code="t">Common aspects of the action of nicotine and other drugs of abuse</subfield>
    <subfield code="v">51</subfield>
    <subfield code="y">1998</subfield>
    <subfield code="o">Picciotto, 1998</subfield>
    <subfield code="s">Drug Alcohol Depend.,51,165</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Posadas, I.</subfield>
    <subfield code="h">López-Hernández, B.</subfield>
    <subfield code="h">Ceña, V.</subfield>
    <subfield code="t">Nicotinic receptors in neurodegeneration</subfield>
    <subfield code="v">11</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">Posadas et al, 2013</subfield>
    <subfield code="s">Curr.Neuropharmacol.,11,298</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Rankovic, Z.</subfield>
    <subfield code="t">CNS drug design: balancing physicochemical properties for optimal brain exposure</subfield>
    <subfield code="v">58</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Rankovic, 2015</subfield>
    <subfield code="s">J.Med.Chem.,58,2584</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Roberts, M.P.</subfield>
    <subfield code="h">Pham, T.Q.</subfield>
    <subfield code="h">Doan, J.</subfield>
    <subfield code="h">Jiang, C.D.</subfield>
    <subfield code="h">Hambley, T.W.</subfield>
    <subfield code="h">Greguric, I.</subfield>
    <subfield code="h">Fraser, B.H.</subfield>
    <subfield code="t">Radiosynthesis and ‘click’conjugation of ethynyl‐4‐[ 18 F]fluorobenzene — an improved [ 18 F]synthon for indirect radiolabeling</subfield>
    <subfield code="v">58</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Roberts et al, 2015</subfield>
    <subfield code="s">J.Labelled Compd Rad,58,473</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Rötering, S.</subfield>
    <subfield code="h">Franke, K.</subfield>
    <subfield code="h">Zessin, J.</subfield>
    <subfield code="h">Brust, P.</subfield>
    <subfield code="h">Füchtner, F.</subfield>
    <subfield code="h">Fischer, S.</subfield>
    <subfield code="h">Steinbach, J.</subfield>
    <subfield code="t">Convenient recycling and reuse of bombarded [¹⁸O]H₂O for the production and the application of [¹⁸F]F⁻</subfield>
    <subfield code="v">101</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Rötering et al, 2015</subfield>
    <subfield code="s">Appl.Radiat.Isotopes,101,44</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Saccone, N.L.</subfield>
    <subfield code="h">Wang, J.C.</subfield>
    <subfield code="h">Breslau, N.</subfield>
    <subfield code="h">Johnson, E.O.</subfield>
    <subfield code="h">Hatsukami, D.</subfield>
    <subfield code="h">Saccone, S.F.</subfield>
    <subfield code="h">Grucza, R.A.</subfield>
    <subfield code="h">Sun, L.</subfield>
    <subfield code="h">Duan, W.</subfield>
    <subfield code="h">Budde, J.</subfield>
    <subfield code="h">Culverhouse, R.C.</subfield>
    <subfield code="h">Fox, L.</subfield>
    <subfield code="h">Hinrichs, A.L.</subfield>
    <subfield code="h">Steinbach, J.H.</subfield>
    <subfield code="h">Wu, M.</subfield>
    <subfield code="h">Rice, J.P.</subfield>
    <subfield code="h">Goate, A.M.</subfield>
    <subfield code="h">Bierut, L.J.</subfield>
    <subfield code="t">The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans</subfield>
    <subfield code="v">69</subfield>
    <subfield code="y">2009</subfield>
    <subfield code="o">Saccone et al, 2009</subfield>
    <subfield code="s">Cancer Res.,69,6848</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Salas, R.</subfield>
    <subfield code="h">Pieri, F.</subfield>
    <subfield code="h">De Biasi, M.</subfield>
    <subfield code="t">Decreased signs of nicotine withdrawal in mice null for the β4 nicotinic acetylcholine receptor subunit</subfield>
    <subfield code="v">24</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Salas et al, 2004</subfield>
    <subfield code="s">J.Neurosci.,24,10035</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Sarasamkan, J.</subfield>
    <subfield code="h">Scheunemann, M.</subfield>
    <subfield code="h">Apaijai, N.</subfield>
    <subfield code="h">Palee, S.</subfield>
    <subfield code="h">Parichatikanond, W.</subfield>
    <subfield code="h">Arunrungvichian, K.</subfield>
    <subfield code="h">Fischer, S.</subfield>
    <subfield code="h">Chattipakorn, S.</subfield>
    <subfield code="h">Deuther-Conrad, W.</subfield>
    <subfield code="h">Schüürmann, G.</subfield>
    <subfield code="h">Brust, P.</subfield>
    <subfield code="h">Vajragupta, O.</subfield>
    <subfield code="t">Varying chirality across nicotinic acetylcholine receptor subtypes: selective binding of quinuclidine triazole compounds</subfield>
    <subfield code="v">7</subfield>
    <subfield code="y">2016</subfield>
    <subfield code="o">Sarasamkan et al, 2016</subfield>
    <subfield code="s">ACS Med.Chem.Lett.,7,890</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Schmidt, V.</subfield>
    <subfield code="t">Comparative anatomy of the pig brain - an integrative magnetic resonance imaging (MRI) study of the porcine brain with special emphasis on the external morphology of the cerebral cortex</subfield>
    <subfield code="p">Universitätsbibliothek Gießen</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="m">(PhD thesis)</subfield>
    <subfield code="o">Schmidt, 2015</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Stoker, A.K.</subfield>
    <subfield code="h">Olivier, B.</subfield>
    <subfield code="h">Markou, A.</subfield>
    <subfield code="t">Role of α7-and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice</subfield>
    <subfield code="v">42</subfield>
    <subfield code="y">2012</subfield>
    <subfield code="o">Stoker et al, 2012</subfield>
    <subfield code="s">Behav.Genet.,42,423</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Stolerman, I.P.</subfield>
    <subfield code="h">Shoaib, M.</subfield>
    <subfield code="t">The neurobiology of tobacco addiction</subfield>
    <subfield code="v">12</subfield>
    <subfield code="y">1991</subfield>
    <subfield code="o">Stolerman and Shoaib, 1991</subfield>
    <subfield code="s">Trends Pharmacol.Sci.,12,467</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Toll, L.</subfield>
    <subfield code="h">Zaveri, N.T.</subfield>
    <subfield code="h">Polgar, W.E.</subfield>
    <subfield code="h">Jiang, F.</subfield>
    <subfield code="h">Khroyan, T.V.</subfield>
    <subfield code="h">Zhou, W.</subfield>
    <subfield code="h">Xie, X.S.</subfield>
    <subfield code="h">Stauber, G.B.</subfield>
    <subfield code="h">Costello, M.R.</subfield>
    <subfield code="h">Leslie, F.M.</subfield>
    <subfield code="t">AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats</subfield>
    <subfield code="v">37</subfield>
    <subfield code="y">2012</subfield>
    <subfield code="o">Toll et al, 2012</subfield>
    <subfield code="s">Neuropsychopharmacol.,37,1367</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Wu, J.</subfield>
    <subfield code="h">Perry, D.C.</subfield>
    <subfield code="h">Bupp, J.E.</subfield>
    <subfield code="h">Jiang, F.</subfield>
    <subfield code="h">Polgar, W.E.</subfield>
    <subfield code="h">Toll, L.</subfield>
    <subfield code="h">Zaveri, N.T.</subfield>
    <subfield code="t">[ 125 I]AT-1012, a new high affinity radioligand for the α3β4 nicotinic acetylcholine receptors</subfield>
    <subfield code="v">77</subfield>
    <subfield code="y">2014</subfield>
    <subfield code="o">Wu et al, 2014</subfield>
    <subfield code="s">Neuropharmacology,77,193</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Zaveri, N.T.</subfield>
    <subfield code="h">Bertrand, S.</subfield>
    <subfield code="h">Yasuda, D.</subfield>
    <subfield code="h">Bertrand, D.</subfield>
    <subfield code="t">Functional characterization of AT-1001, an α3β4 nicotinic acetylcholine receptor ligand, at human α3β4 and α4β2 nAChR</subfield>
    <subfield code="v">17</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Zaveri et al, 2015</subfield>
    <subfield code="s">Nicotine Tob.Res.,17,361</subfield>
  </datafield>
  <datafield tag="FFT" ind1=" " ind2=" ">
    <subfield code="a">/afs/cern.ch/project/inspire/uploads/elsevier/consyn/consyn-files/0969-8043/aip/S096980431730252X/S096980431730252X.xml</subfield>
    <subfield code="t">Elsevier</subfield>
    <subfield code="o">HIDDEN</subfield>
  </datafield>
</record>